bioRxivNeurosciencePreprint
Ubiquitin ligase LNX1 is a major regulator of glycine recapture by the presynaptic transporter GlyT2
Estefanía NúñeziD, Esther Arribas-GonzáleziD, Beatriz López‐CorcueraiD, Carmen Aragón, Jaime de Juan‐SanziD
Abstract
The neuronal glycine transporter GlyT2 is an essential regulator of glycinergic neurotransmission that recaptures glycine in presynaptic terminals to facilitate quantal transmitter packaging in synaptic vesicles. Alterations in GlyT2 expression or activity result in lower cytosolic glycine levels, emptying glycinergic synaptic vesicles and impairing neurotransmission. Lack of glycinergic neurotransmission caused by GlyT2 loss-of-function mutations results in Hyperekplexia, a rare neurological disease characterized by generalized stiffness and motor alterations that may result in sudden infant death. Although the importance of GlyT2 in pathology is known, how this transporter is regulated at the molecular level is poorly understood, limiting current therapeutic strategies. Guided by an unbiased screening, we discovered that the E3 ubiquitin ligase Ligand of Numb protein X1 (LNX1) modulates the ubiquitination status of GlyT2. LNX1 ubiquitinates a cytoplasmic C-terminal lysine cluster in GlyT2 (K751, K773, K787 and K791) through its N-terminal RING-finger domain, and this process regulates the expression levels and transport activity of GlyT2 in neurons. These experiments reveal for the first time the identity of an E3 ubiquitin-ligase acting on GlyT2 and identify a novel regulatory mechanism by which neurons regulate GlyT2 expression and activity.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The presynaptic glycine transporter GlyT2 is regulated by the Hedgehog pathway in vitro and in vivo
Andrés de la Rocha‐Muñoz, Enrique Núñez, … Carmen Aragón·Communications BiologyPeer-reviewed·Oct 18, 2021
- Rescue of two trafficking-defective variants of the neuronal glycine transporter GlyT2 associated to hyperekplexia
Andrés de la Rocha‐Muñoz, Elena Melgarejo, … Beatriz López‐Corcuera·NeuropharmacologyPeer-reviewed·Mar 29, 2021
- Structural insights into glycine reuptake inhibition
Azadeh Shahsavar, Peter Stohler, … Poul Nissen·NaturePeer-reviewed·Mar 3, 2021
- Dynamic role of GlyT1 as glycine sink or source: pharmacological implications for the gain control of NMDA receptors
Stéphane Supplisson·NeurosciencePeer-reviewed·Jul 24, 2024
- Neurexins control the strength and precise timing of glycinergic inhibition in the auditory brainstem
He-Hai Jiang, Ruoxuan Xu, … Fujun Luo·eLifePeer-reviewed·May 30, 2024
- A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects
Ryan Cantwell Chater, Julian Peiser-Oliver, … Azadeh Shahsavar·bioRxiv·Apr 21, 2025